Financial results - POLICLINICA DR.CITU SRL

Financial Summary - Policlinica Dr.citu Srl
Unique identification code: 5016466
Registration number: J35/4227/1993
Nace: 8622
Sales - Ron
250.893
Net Profit - Ron
23.347
Employee
9
The most important financial indicators for the company Policlinica Dr.citu Srl - Unique Identification Number 5016466: sales in 2023 was 250.893 euro, registering a net profit of 23.347 euro and having an average number of 9 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Policlinica Dr.citu Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 126.033 169.285 172.504 186.358 219.832 301.259 253.575 308.598 280.711 250.893
Total Income - EUR 126.132 169.312 172.539 186.383 222.055 301.675 271.522 309.543 282.273 251.509
Total Expenses - EUR 91.158 92.186 132.785 141.978 137.740 220.345 223.450 255.004 230.343 225.709
Gross Profit/Loss - EUR 34.974 77.126 39.754 44.405 84.315 81.330 48.072 54.539 51.930 25.800
Net Profit/Loss - EUR 30.720 64.980 33.207 42.235 82.095 77.559 45.785 51.261 49.164 23.347
Employees 4 15 5 6 5 5 5 5 14 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -10.4%, from 280.711 euro in the year 2022, to 250.893 euro in 2023. The Net Profit decreased by -25.668 euro, from 49.164 euro in 2022, to 23.347 in the last year.

Check the financial reports for the company - Policlinica Dr.citu Srl

Rating financiar

Financial Rating -
Policlinica Dr.citu Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Policlinica Dr.citu Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Policlinica Dr.citu Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Policlinica Dr.citu Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Policlinica Dr.citu Srl - CUI 5016466

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 77.521 75.435 83.404 77.504 19.983 13.541 104.175 103.782 70.465 32.212
Current Assets 257.955 321.009 347.624 361.798 379.290 436.830 480.760 429.557 387.079 368.237
Inventories 0 0 0 0 0 2.013 2.801 0 12.086 0
Receivables 199.241 198.274 183.638 354.620 369.125 394.874 373.675 389.983 369.155 351.169
Cash 58.714 122.734 163.985 7.178 10.165 39.943 104.283 39.575 5.838 17.068
Shareholders Funds 312.999 378.796 408.140 423.767 485.191 506.993 532.278 475.979 422.979 368.944
Social Capital 19.054 19.213 19.017 18.695 18.352 17.996 17.655 17.264 17.317 17.265
Debts 22.477 17.647 22.888 15.535 11.598 12.240 103.625 91.825 60.869 31.505
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 368.237 euro in 2023 which includes Inventories of 0 euro, Receivables of 351.169 euro and cash availability of 17.068 euro.
The company's Equity was valued at 368.944 euro, while total Liabilities amounted to 31.505 euro. Equity decreased by -52.752 euro, from 422.979 euro in 2022, to 368.944 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Policlinica Dr.citu Srl

Comments - Policlinica Dr.citu Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.